Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
BILASTINE Grey Allergic rhinoconjunctivitis and urticaria
BIMEKIZUMAB (Bimzelx®) (NEW) Red For treating axial spondyloarthritis in adults

In line with NICE TA918

BIMEKIZUMAB (Bimzelx®)) (NEW) Red For treating active psoriatic arthritis in adults.

In line with NICE TA916

FAECAL MICROBIOME TRANSPLANT (NEW) Red Treatment resistant reatment resistant C.difficile
PEGFILGRASTIM (NEW) Red Treatment of neutropenia in children and TYA patients
SEMAGLUTIDE (Wegovy®) (UPDATED) Red Management of obesity in adolescents

Only through a specialist weight management service.

TIRBANIBULIN (Klisyri®) (NEW) Green Grade 1 Actinic Keratoses for the face and scalp

Single treatment course only – not to be repeated.

Other Updates on this Website

Recent documents from LLR APC and TAS

About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more